124 related articles for article (PubMed ID: 10774640)
1. Systemic vancomycin overexposure in a patient with spinal cord injury who had Staphylococcal sepsis and Clostridium difficile colitis.
Pea F; Furlanut M; Bianchi L
Ther Drug Monit; 2000 Apr; 22(2):233-4. PubMed ID: 10774640
[No Abstract] [Full Text] [Related]
2. Pseudomembranous colitis in spinal cord injury.
Johnson DK; Balmaseda MT
Arch Phys Med Rehabil; 1985 Jun; 66(6):394-6. PubMed ID: 4004539
[TBL] [Abstract][Full Text] [Related]
3. Significant absorption of oral vancomycin in a patient with clostridium difficile colitis and normal renal function.
Aradhyula S; Manian FA; Hafidh SA; Bhutto SS; Alpert MA
South Med J; 2006 May; 99(5):518-20. PubMed ID: 16711316
[TBL] [Abstract][Full Text] [Related]
4. Vancomycin drug monitoring in infants with CoNS sepsis-target attainment, microbiological response and nephrotoxicity.
Viel-Thériault I; Martin B; Thompson-Desormeaux F; Blackburn J; Moussa A; Autmizguine J
J Perinatol; 2020 Jan; 40(1):97-104. PubMed ID: 31576000
[TBL] [Abstract][Full Text] [Related]
5. [Vancomycin: treatment of staphylococcal septicemias and pseudomembranous colitis].
Chevrel B
Med Chir Dig; 1982; 11(3):217-21. PubMed ID: 7098605
[No Abstract] [Full Text] [Related]
6. Staphylococcal enterocolitis--treatment with oral vancomycin.
Khan MY; Hall WH
Ann Intern Med; 1966 Jul; 65(1):1-8. PubMed ID: 5936663
[No Abstract] [Full Text] [Related]
7. Systemic absorption of oral vancomycin in patients with Clostridium difficile infection.
Rao S; Kupfer Y; Pagala M; Chapnick E; Tessler S
Scand J Infect Dis; 2011 May; 43(5):386-8. PubMed ID: 21198337
[TBL] [Abstract][Full Text] [Related]
8. Oral vancomycin may have significant absorption in patients with Clostridium difficile colitis.
Chihara S; Shimizu R; Furukata S; Hoshino K
Scand J Infect Dis; 2011 Feb; 43(2):149-50. PubMed ID: 20831355
[TBL] [Abstract][Full Text] [Related]
9. Intracolonic use of vancomycin for treatment of clostridium difficile colitis in a patient with a diverted colon: report of a case.
Nathanson DR; Sheahan M; Chao L; Wallack MK
Dis Colon Rectum; 2001 Dec; 44(12):1871-2. PubMed ID: 11742178
[TBL] [Abstract][Full Text] [Related]
10. Oxacillin-induced pseudomembranous colitis.
Friedman RJ; Mayer IE; Galambos JT; Hersh T
Am J Gastroenterol; 1980 May; 73(5):445-7. PubMed ID: 7416143
[TBL] [Abstract][Full Text] [Related]
11. Vancomycin Trough Concentration as a Predictor of Clinical Outcomes in Patients with Staphylococcus aureus Bacteremia: A Meta-analysis of Observational Studies.
Prybylski JP
Pharmacotherapy; 2015 Oct; 35(10):889-98. PubMed ID: 26497475
[TBL] [Abstract][Full Text] [Related]
12. Intracolonic Vancomycin Through Laprascopic Appendicostomy for Treatment of Severe Clostridium difficile Colitis Does Not Get Systemic Absorption.
Alhazmi L; Almeshal N; Assaly R
Am J Ther; 2017; 24(5):e616. PubMed ID: 28301334
[No Abstract] [Full Text] [Related]
13. Pseudomembranous enterocolitis. A comparison with staphylococcal colitis.
Strickler JH; Rice CO
Minn Med; 1966 Jun; 49(6):899-904. PubMed ID: 5933702
[No Abstract] [Full Text] [Related]
14. [Persistent bacteremia due to methicillin-resistant Staphylococcus aureus. A result of inadequate treatment].
Parra-Ruiz J; Tomas-Jiménez C; Muñoz-Medina L; Hernández-Quero J
Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):372-3. PubMed ID: 19339080
[No Abstract] [Full Text] [Related]
15. Association Between Vancomycin Trough Concentrations and Duration of Methicillin-Resistant Staphylococcus aureus Bacteremia in Children.
Hsu AJ; Hamdy RF; Huang Y; Olson JA; Ghobrial S; Gerber JS; Hersh AL; Tamma PD
J Pediatric Infect Dis Soc; 2018 Dec; 7(4):338-341. PubMed ID: 28992126
[TBL] [Abstract][Full Text] [Related]
16. Systemic absorption of enteral vancomycin in a patient with pseudomembranous colitis.
Spitzer PG; Eliopoulos GM
Ann Intern Med; 1984 Apr; 100(4):533-4. PubMed ID: 6703548
[No Abstract] [Full Text] [Related]
17. A case of Clostridium difficile bacteremia in a patient with loop ileostomy.
Choi JL; Kim BR; Kim JE; Woo KS; Kim KH; Kim JM; Lee SE; Han JY
Ann Lab Med; 2013 May; 33(3):200-2. PubMed ID: 23667848
[TBL] [Abstract][Full Text] [Related]
18. Highlights from the 27th ECCMID.
McConnell J; Sekkides O
Lancet Infect Dis; 2017 Jun; 17(6):586-587. PubMed ID: 28555585
[No Abstract] [Full Text] [Related]
19. Severe Clostridium difficile colitis: the role of intracolonic vancomycin?
Apisarnthanarak A; Khoury H; Reinus WR; Crippin JS; Mundy LM
Am J Med; 2002 Mar; 112(4):328-9. PubMed ID: 11893379
[No Abstract] [Full Text] [Related]
20. Clostridium difficile and cytotoxin in feces of patients with antimicrobial agent-associated pseudomembranous colitis.
George WL; Rolfe RD; Harding GK; Klein R; Putnam CW; Finegold SM
Infection; 1982; 10(4):205-8. PubMed ID: 7129642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
